Eris launch coincides with a parallel entry by Natco Pharma, which will also bring its semaglutide injections to market on ...

Add Yahoo as a preferred source to see more of our stories on Google. A coronavirus variant nicknamed "Eris" is now thought to be the dominant strain in the US. The variant was discovered in February, ...

Eris Lifesciences partners with Natco Pharma to commercialise semaglutide in India in 2026, as rising demand and impending ...

Wearing masks remains a great way to protect yourself from airborne infections. As summer winds down, there’s a new COVID variant on the rise. EG.5.1, nicknamed the “Eris” variant, has become the ...

The company said it is introducing the diabetes and weight management medication in multi-dose vial formats at highly ...

Eris Lifesciences Limited, a leading Indian branded formulations company, has announced a breakthrough diabetes therapy with the launch of weekly shot of its generic semaglutide starting at Rs. 220 ...

A new coronavirus subvariant, nicknamed Eris, has rapidly risen to prominence nationwide and is now thought to account for more U.S. cases than any of its counterparts at a time when transmission has ...